Header cover image

Japanese (NIKKEI) Pharma Industry Analysis

UpdatedDec 23, 2025
DataAggregated Company Financials
Companies40
  • 7D-1.5%
  • 3M11.4%
  • 1Y9.9%
  • YTD10.3%

Over the last 7 days, the Pharma industry has dropped 1.5%, driven by a pullback from Daiichi Sankyo Company of 2.2%. In contrast, Takeda Pharmaceutical has gained 6.8%. In the past year, the industry has gained 9.9%. As for the next few years, earnings are expected to grow by 11% per annum.

Industry Valuation and Performance

Has the Japanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 24 Dec 2025JP¥45.5tJP¥16.9tJP¥1.9t16.4x23.9x2.7x
Fri, 21 Nov 2025JP¥45.0tJP¥16.9tJP¥1.9t15.3x23.7x2.7x
Sun, 19 Oct 2025JP¥41.2tJP¥16.8tJP¥1.8t15x22.5x2.5x
Tue, 16 Sep 2025JP¥41.5tJP¥16.8tJP¥1.8t16.3x22.7x2.5x
Thu, 14 Aug 2025JP¥40.2tJP¥16.8tJP¥1.8t16.1x22x2.4x
Sat, 12 Jul 2025JP¥38.7tJP¥16.8tJP¥1.8t15.1x22x2.3x
Mon, 09 Jun 2025JP¥40.3tJP¥16.8tJP¥1.8t14.3x22.8x2.4x
Wed, 07 May 2025JP¥43.0tJP¥16.7tJP¥1.7t15x25.4x2.6x
Fri, 04 Apr 2025JP¥39.2tJP¥16.5tJP¥1.5t14.6x26.1x2.4x
Sun, 02 Mar 2025JP¥40.4tJP¥16.5tJP¥1.5t15.5x26.9x2.5x
Tue, 28 Jan 2025JP¥41.0tJP¥16.1tJP¥1.4t16x29.1x2.5x
Thu, 26 Dec 2024JP¥41.9tJP¥16.1tJP¥1.4t15.9x29.7x2.6x
Sat, 23 Nov 2024JP¥41.4tJP¥16.1tJP¥1.4t15x29.3x2.6x
Mon, 21 Oct 2024JP¥44.9tJP¥15.6tJP¥1.2t15.8x37.4x2.9x
Wed, 18 Sep 2024JP¥44.1tJP¥15.5tJP¥1.2t17.7x36.7x2.8x
Fri, 16 Aug 2024JP¥45.4tJP¥15.5tJP¥1.2t16.7x37.8x2.9x
Sun, 14 Jul 2024JP¥45.4tJP¥15.0tJP¥1.1t19.1x41.4x3x
Tue, 11 Jun 2024JP¥41.4tJP¥15.0tJP¥1.1t18x37.8x2.8x
Thu, 09 May 2024JP¥40.5tJP¥14.9tJP¥1.3t18.6x32.3x2.7x
Sat, 06 Apr 2024JP¥41.0tJP¥15.1tJP¥1.2t19.2x33.7x2.7x
Mon, 04 Mar 2024JP¥43.4tJP¥15.1tJP¥1.2t20x35.7x2.9x
Wed, 31 Jan 2024JP¥40.6tJP¥15.2tJP¥1.4t20.7x29.6x2.7x
Fri, 29 Dec 2023JP¥38.8tJP¥15.2tJP¥1.4t19.4x28.2x2.6x
Sun, 26 Nov 2023JP¥39.7tJP¥15.2tJP¥1.4t20.2x28.9x2.6x
Tue, 24 Oct 2023JP¥39.0tJP¥14.9tJP¥1.4t23.4x27.3x2.6x
Thu, 21 Sep 2023JP¥40.5tJP¥14.9tJP¥1.4t24.6x28.4x2.7x
Sat, 19 Aug 2023JP¥39.6tJP¥14.9tJP¥1.4t22.3x27.7x2.7x
Mon, 17 Jul 2023JP¥37.3tJP¥14.6tJP¥1.5t20x25.5x2.6x
Wed, 14 Jun 2023JP¥42.2tJP¥14.6tJP¥1.5t20.3x28.8x2.9x
Fri, 12 May 2023JP¥38.4tJP¥14.5tJP¥1.4t18x27.1x2.6x
Sun, 09 Apr 2023JP¥36.9tJP¥14.3tJP¥1.5t17x25.1x2.6x
Tue, 07 Mar 2023JP¥36.8tJP¥14.3tJP¥1.5t16.5x25x2.6x
Thu, 02 Feb 2023JP¥36.3tJP¥13.9tJP¥1.4t19.1x25.5x2.6x
Sat, 31 Dec 2022JP¥37.6tJP¥13.7tJP¥1.3t18.3x27.9x2.8x
Price to Earnings Ratio

27.9x


Total Market Cap: JP¥37.6tTotal Earnings: JP¥1.3tTotal Revenue: JP¥13.7tTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Pharma Industry Price to Earnings3Y Average 28.8x202320242025
Current Industry PE
  • Investors are pessimistic on the Japanese Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 23.9x which is lower than its 3-year average PE of 28.8x.
  • The industry is trading close to its 3-year average PS ratio of 2.6x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 12% per year over the last three years.
  • Revenues for these companies have grown 7.4% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare industry?

JP Market-0.56%
Healthcare-1.11%
Pharma-1.47%
Pharma-1.47%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4502 Takeda PharmaceuticalJP¥4.82k6.8%
+JP¥481.8b
17.2%PE230.3x
4519 Chugai PharmaceuticalJP¥8.34k0.9%
+JP¥116.8b
20.5%PE34.6x
4507 ShionogiJP¥2.79k0.9%
+JP¥20.8b
26.1%PE13.9x
4506 Sumitomo PharmaJP¥2.31k2.0%
+JP¥17.9b
306.8%PE5.9x
4540 TsumuraJP¥4.14k4.2%
+JP¥12.5b
-12.4%PE11.2x

Latest News